SERUM INSTITUTE : SUPPLY COVID -19 VACCINE AT RS 250 A DOSE
Serum Institute and Bharat Biotech, both Indian firms, followed next.
Hopes for an early vaccine for the coronavirus disease (Covid-19) in India have been rekindled after three firms, within days of each other, applied for emergency use authorisation (EUA) of their respective vaccine candidates in the country. While America’s Pfizer Inc was the first to apply on December 4, Pune-based Serum Institute of India (SII) and Hyderabad-based Bharat Biotech International Limited applied on December 6 and 7 respectively.
Tags : Indian,